Medical Treatments for Obesity: What Does the Future Have in Store?

A systematic-search review of the obesity-pharmacotherapy landscape that positions tirzepatide among the highest-efficacy agents and looks ahead to multi-pathway drugs like retatrutide and CagriSema. As a narrative synthesis it aggregates trial findings rather than adding new data, and many named agents fall outside our tracked list. Useful for context and framing where the field is heading, with tirzepatide as the main tracked peptide.